Basic and Diluted Loss per Share (Details) - $ / shares |
6 Months Ended | ||
|---|---|---|---|
Jun. 30, 2022 |
Jun. 30, 2021 |
Jun. 30, 2022 |
|
| Basic and Diluted Loss per Share (Details) [Line Items] | |||
| Options to purchase shares | 867,012 | 856,493 | |
| Exercise price (in Dollars per share) | $ 0.121 | $ 0.088 | |
| Convertible shares of common stock | 7,731,043 | ||
| Preferred Stock [Member] | |||
| Basic and Diluted Loss per Share (Details) [Line Items] | |||
| Convertible shares outstanding | 178,281 | ||
| Common Stock [Member] | |||
| Basic and Diluted Loss per Share (Details) [Line Items] | |||
| Convertible shares outstanding | 48,082 | 121,990 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The warrants are convertible into common stock. No definition available.
|
| X | ||||||||||
- Definition Number of shares of common stock issued as dividends during the period. Excludes stock splits. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of shares that could be issued to net share settle a contract, if applicable. If a contract does not have a fixed or determinable maximum number of shares that may be required to be issued, disclose the fact that a potentially infinite number of shares could be issued to settle the contract. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|